MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
03.02.2022
voting rights
21
Apr
2022
16
Feb
2022
SVB Leerink 11th Annual Global Healthcare Conference
Jean-Paul Kress, M.D. (CEO, MorphoSys) presents the Company on 2.16.22 at 8:00AM – 8:30AM ET / 2:00pm – 2:30pm CET.
16
Nov
2022
03
Aug
2022
05
May
2022
Conference Call and Webcast: First Quarter 2022 Results
Here you have the option to access a replay of the conference call on the company's website.
Presentation for the Q1 2022 results.
17
Mar
2022
Year-End Results 2021 Conference Call and Webcast
Here you have the option to access a replay of the conference call on the company's website.
18
May
2022
You are now leaving the MorphoSys.com website. This link will take you to a different website. You are solely responsible for your interactions with that website.
Do you wish to proceed ?
Are you a U.S. resident? This portion of the MorphoSys website is intended for U.S. residents only. It is not for individuals living in Germany or other European Union member states.
Do you wish to proceed ?
MorphoSys is providing the data presented at medical congresses as part of scientific exchange. The scientific information may include data/information on investigational use(s) of compounds/drugs of which the efficacy and safety have not yet been established. Information available on this website is not intended to promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of MorphoSys’ products. Copies of congress presentations may not be reproduced without written permission from the congress and the authors.
Are you a U.S. resident? This portion of the MorphoSys website is intended for U.S. residents only. It is not for individuals living in Germany or other European Union member states.